BLACK DIAMOND THERAPEUTICS, INC.: operating cash flow
Operating cash flow for BLACK DIAMOND THERAPEUTICS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All BLACK DIAMOND THERAPEUTICS, INC. financial histories
What this measure means
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
Exact concept: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2018-01-01 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 29,614,000 | USD | 2026-03-16 | 10-K · 0001701541-26-000009 |
| 2024-01-01 | 2024-12-31 | -62,303,000 | USD | 2026-03-16 | 10-K · 0001701541-26-000009 |
| 2023-01-01 | 2023-12-31 | -66,717,000 | USD | 2025-03-06 | 10-K · 0001701541-25-000016 |
| 2022-01-01 | 2022-12-31 | -85,082,000 | USD | 2024-03-12 | 10-K · 0001701541-24-000011 |
| 2021-01-01 | 2021-12-31 | -100,148,000 | USD | 2023-03-09 | 10-K · 0001701541-23-000020 |
| 2020-01-01 | 2020-12-31 | -52,146,000 | USD | 2022-03-17 | 10-K · 0001701541-22-000007 |
| 2019-01-01 | 2019-12-31 | -24,674,000 | USD | 2021-03-25 | 10-K · 0001701541-21-000018 |
| 2018-01-01 | 2018-12-31 | -8,454,000 | USD | 2020-03-24 | 10-K · 0001701541-20-000009 |
Related financial histories
- BLACK DIAMOND THERAPEUTICS, INC.: total assets
- BLACK DIAMOND THERAPEUTICS, INC.: total liabilities
- BLACK DIAMOND THERAPEUTICS, INC.: stockholders equity
- BLACK DIAMOND THERAPEUTICS, INC.: cash and cash equivalents
- BLACK DIAMOND THERAPEUTICS, INC.: net income or loss
- BLACK DIAMOND THERAPEUTICS, INC.: capital expenditure payments
- BLACK DIAMOND THERAPEUTICS, INC.: contract revenue excluding tax
- BLACK DIAMOND THERAPEUTICS, INC.: financing cash flow
- BLACK DIAMOND THERAPEUTICS, INC.: investing cash flow
- BLACK DIAMOND THERAPEUTICS, INC.: retained earnings or deficit
- BLACK DIAMOND THERAPEUTICS, INC.: basic weighted-average shares
- BLACK DIAMOND THERAPEUTICS, INC.: diluted weighted-average shares
- BLACK DIAMOND THERAPEUTICS, INC.: basic earnings per share
- BLACK DIAMOND THERAPEUTICS, INC.: diluted earnings per share
- BLACK DIAMOND THERAPEUTICS, INC.: net property, plant and equipment
- BLACK DIAMOND THERAPEUTICS, INC.: share-based compensation expense
- BLACK DIAMOND THERAPEUTICS, INC.: operating income or loss
- BLACK DIAMOND THERAPEUTICS, INC.: current assets
- BLACK DIAMOND THERAPEUTICS, INC.: interest expense
- BLACK DIAMOND THERAPEUTICS, INC.: current liabilities
- BLACK DIAMOND THERAPEUTICS, INC.: current accounts payable
- BLACK DIAMOND THERAPEUTICS, INC.: operating expenses
- BLACK DIAMOND THERAPEUTICS, INC.: research and development expense
Inspect the source
- Entity
- BLACK DIAMOND THERAPEUTICS, INC. / CIK 0001701541
- Captured
- 2026-09-19T11:20:29.105Z
- SEC response SHA-256
83c9b39ed87bea5941c5d66910af8cb00c0034506f171838a44f7760e1828384
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001701541.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))